{"nct_id":"NCT02370498","title":"A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2015-05-11","start_date_type":"ACTUAL","primary_completion_date":"2017-10-26","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}